Parameter | Possible answers | No. of primary care pediatricians | Percentage |
---|---|---|---|
Percentage of pre-school children for whom NSI is recommended | |||
None | 6/860 | 0.7 | |
<25% | 44/860 | 5.1 | |
25-75% | 452/860 | 52.5 | |
>75% | 358/860 | 41.6 | |
Age of patients for whom NSI is considered important | |||
All pre-school years | 473/854 | 43.7 | |
<1 year | 323/854 | 37.8 | |
1-2 year | 37/854 | 4.3 | |
2-3 years | 121/854 | 14.2 | |
Use of NSI for upper respiratory tract diseases | |||
Treatment of acute phase | 339/854 | 39.7 | |
Prophylaxis in healthy children | 515/854 | 60.3 | |
Frequency of therapeutic administration of NSI | |||
Once per day | 317/854 | 37.1 | |
2-3 times per day | 412/854 | 48.2 | |
>3 times per day | 125/854 | 14.7 | |
Frequency of prophylactic administration of NSI | |||
Never | 339/854 | 39.7 | |
Daily | 80/515 | 15.5 | |
3-4 times per week | 435/515 | 84.5 | |
Type of solution | |||
Isotonic saline solution | 743/854 | 87.0 | |
Hypertonic saline solution | 67/854 | 7.8 | |
Hypotonic saline solution | 44/854 | 5.2 | |
Method of administration | |||
Spray | 578/854 | 67.7 | |
Bulb syringe | 176/854 | 20.6 | |
Gravity | 100/854 | 11.7 | |
Volume of solution recommended for NSI | |||
Depending on patient age | 196/854 | 23.0 | |
5-20 mL per nostril | 241/854 | 28.2 | |
5 mL per nostril | 157/854 | 18.4 | |
2.5 mL per nostril | 177/854 | 20.7 | |
Other | 83/854 | 9.7 | |
Final evaluation of efficacy and safety of NSI | |||
Effective and safe | 845/860 | 98.3 | |
Effective but poorly tolerated | 9/860 | 1.0 | |
Ineffective | 2/860 | 0.2 | |
No opinion | 4/860 | 0.5 |